HomeMachinery & EquipmentIndustrial Equipment Pharmaceuticals Lipids Market

Pharmaceutical Lipids Market Size, Share & Trends Analysis Report By Product (Triglycerides, Phospholipids, Sphingolipids, Cholesterol, Fatty Acids), By Source (Synthetic, Semi-Synthetic, Natural), By Form (Liquid, Semi-Solid, Solid), By Application (Conventional Lipid-Based Drug Delivery Systems, Self-Emulsifying Drug Delivery Systems, Liposomes, Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, Others), By Route of Administration (Oral, Tablet, Solution, Parenteral, Intravenous, Intramuscular, Topical), By Region (North America, Europe, APAC, Middle East and Africa, LATAM), Forecasts, 2026-2034

Last Updated: October 26, 2026 | Author: Ismail Sutaria | Format:

Pharmaceuticals Lipids Market Size

The global pharmaceuticals lipids market size was valued at USD 5.45 billion in 2025 and is projected to grow from USD 5.73 billion in 2026 to USD 8.60 billion by 2034, registering a CAGR of 5.2% during the forecast period from 2026 to 2034. North America dominated the pharmaceuticals lipids market with a market share of 39.5% in 2025.

In the pharmaceutical business, lipids and polymers are regarded as two of the essential excipients that can be used in drug formation. They are utilized in various capacities, including stabilizers, solubilizers, permeation enhancers, transfection agents, and others. Using a broad range of natural, synthetic, semi-synthetic, or entirely artificial lipids and polymers in developing various dosage forms is anticipated to drive market growth over the ensuing period.

The increasing demand for medications worldwide is driving the manufacture of liposomal pharmaceuticals to treat cancer and excipients. The American Association of Pharmaceutical Scientists (AAPS) reports that approximately 90% of pharmaceuticals are still in the research and development phase, and 40% of drugs currently on the market have poor solubility in water. It has increased demand for lipid-based formulations in pharmaceuticals, diagnostics, vaccines, and nutraceuticals.

Pharmaceuticals Lipids Market Size , Share and Growth Forecast 2026-2034

Download a Free SampleTo learn more about this report.

01

Increase in Neurological, Cardiovascular, and Cancer Patients to Support Market Growth

There has been a significant uptick in most neurological conditions worldwide, including Alzheimer's, dementia, epilepsy, stroke, multiple sclerosis, and migraine, Parkinson's disease, and brain tumors. Because of the rising prevalence of these disorders, it is of the utmost importance to research, produce, and make available effective medicines to treat these conditions. As a result of the fact that lipids' active pharmaceutical substances provide crucial medicinal effects to these patients and help in the healing process, their use and incorporation in medications have expanded significantly, which has benefited the market. Furthermore, according to statistics from the World Health Organization (WHO), cardiovascular illnesses are the leading cause of death globally, accounting for almost 17 million fatalities annually. The prevalence of cardiovascular diseases has increased dramatically over the past few decades due to people's sedentary lifestyles and poor eating habits.s

01

Improvements in the Product Quality to Hinder Market Growth

Stringent quality regulations by various governments worldwide have significantly impacted the market's growth because manufacturers of the active pharmaceutical components found in lipids cannot improve the process design. These quality standards have a detrimental effect on producers' profitability and increase the time and money spent on product development. GMP, which stands for "Good Manufacturing Practices," ICH, which stands for "International Conference on Harmonization," and cGMP are a few examples of these standards (current GMP). In addition, patent expirations have been a significant obstacle to revenue development. These issues make it more challenging to maintain a steady supply of lipids' active medicinal ingredients on a more significant and widespread scale worldwide.

01

Rising Demand for Effective and Fast-Acting Medications to Spur Market Opportunities

Expanding the medical community's understanding of the therapeutic and curative potential of lipid-based active pharmaceutical ingredients has a beneficial impact on the use of these compounds in pharmaceutical products worldwide. Multiple organizations, firms, and educational institutions are currently engaged in significant research and development operations to enhance the effects of these substances. This has resulted in the general acceptance of lipids' active pharmaceutical ingredients in various medicinal treatments and has presented the lucrative potential for expanding the market.

In addition, considerable potential for expansion has been established due to the rising demand among healthcare businesses for both practical and quick-acting pharmaceuticals in treating various diseases and conditions, including cancer, cardiovascular disorders, and others. In addition, manufacturers can now generate vast quantities of lipids' active pharmaceutical ingredients due to the continual development of more sophisticated and superior facilities for the synthesis of drugs. As a result of an increase in their manufacturing, their application in various contexts will expand.

Product Insights

The triglycerides market category is the most dominant and is expected to grow at a CAGR of 5.1% during the forecast period. Many different types of personal care products use these lipids in various ways. For example, caprylic triglyceride or capric triglyceride production involves the combination of glycerine and the fatty acids found in natural oils such as coconut oil. Binding other components, including essential oils, are standard in cosmetics and soaps.

Pharmaceuticals Lipids Market Size By Segments

Request Customizationto receive a tailored report.

Source Insights

Demand for products derived from semi-synthetic sources is anticipated to grow at a CAGR of 5.8% during the forecast period. The chemical structure of semi-synthetic pharmaceuticals is modified, but the nucleus of the medication derived from a natural source is maintained in its original form. Heroin is derived from morphine; bromoscopolamine, derived from scopolamine; homatropine, derived from atropine; ampicillin, derived from penicillin; and so on are all examples of semi-synthetic medications. Plants are the most common source of natural medicines due to their chemical and structural variety and their wide variety of constituent parts. Aspirin, oral anti-diabetics, antihistamines, amphetamine, chloroquine, chlorpromazine, and general and local anesthetics are all medications prepared synthetically.

Form Insights

It is anticipated that the semi-solid segment will dominate the market. Cosmetic formulations with nano-drug delivery systems are referred to as nano-cosmeceuticals. These formulations are intended to convey active compounds to the appropriate skin tissues. Many different kinds of semi-solid nanostructured lipid carriers are utilized for medication delivery.

Application Insights

The market is segmented into Liposomes, solid lipid nanoparticles; nanostructured lipid carriers; conventional lipid-based drug delivery systems; self-emulsifying drug delivery systems; self-micro emulsifying drug delivery systems; conventional lipid-based drug delivery systems.

The conventional lipid-based drug delivery systems (LBDDS) segment will dominate the market. One of the developing technologies aiming to solve difficulties such as the solubility and bioavailability of poorly water-soluble pharmaceuticals is LBDDS. The requirements are determined by the disease indication, route of administration, cost considerations, product stability, toxicity, and efficacy. Lipid-based formulations can be adapted to fulfill all of these needs.

Route of Administration Insights

The oral lipids segment dominates the market during the forecast period. Oral formulations based on lipids are gaining popularity because they increase the solubility of poorly water-soluble and lipophilic drugs. It also facilitates absorption of these drugs through the gastrointestinal tract and reduces or eliminates the effect of food on the absorption of these drugs.

Pharmaceuticals Lipids Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

It is anticipated that the market in North America will represent a sizable income share in the global market for medication lipids due to the enormous amount the government spends on the research and development of new drugs. Factors such as the availability of cutting-edge infrastructure for research and development activities and many players operating in the nation will help the market flourish. In addition, leading market players' method toward business expansion through acquisitions is relied upon to assist in developing the market. The United States will continue to see significant demand during the forecast period.

North America Pharmaceuticals Lipids Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific: Growing Region

The Asia-Pacific area is developing quickly, and a significant portion of its growth is invested in research and development operations to create more effective medicines. In addition, an upsurge in the number of people with cancer, cardiovascular diseases, and neurological disorders particularly in China, India, and Japan has resulted in a tremendous increase in lipids as active medicinal ingredients in the manufacture of medicines.

List of Key and Emerging Players in Pharmaceuticals Lipids Market

ABITEC Corporation (ABF Ingredients)
BASF SE
Croda International Plc
CordenPharma
NOF (Nippon Oil & Fats) Corporation
Cayman Chemical Company
Lipoid GmbH
Nippon Fine Chemical Co. Ltd.
Dishman Group
Gattefosse
IOI Oleo GmbH
Stepan Company
Evonik Industries AG

Key Industry Developments

October 2025
Croda International Plc expanded its pharmaceutical excipients portfolio by introducing additional Super Refined™ pharmaceutical lipids for lipid nanoparticle (LNP) manufacturing. The expansion supports growing demand from mRNA vaccine and gene therapy developers for GMP-grade lipid excipients with enhanced purity and scalability.
September 2025
Biocytogen Pharmaceuticals and Merck announced a collaboration to develop antibody-conjugated lipid-based delivery technologies, including antibody-conjugated lipid nanoparticles for nucleic acid therapeutics. The partnership aims to improve targeted delivery efficiency for oncology and other therapeutic applications while advancing lipid-based drug delivery platforms.
September 2025
Cayman Chemical entered a strategic partnership with Curapath to commercialize PEG-free shielding lipids for lipid nanoparticle (LNP) formulations. Under the agreement, Cayman Chemical will distribute Curapath's proprietary polysarcosine (pSar)- and polyamino acid-based lipids globally, enabling developers of mRNA therapeutics and gene therapies to access next-generation biodegradable lipid excipients.
June 2025
NOF CORPORATION launched Lipidure®-CRG Series, a new range of high-purity ionizable lipids designed for lipid nanoparticle (LNP)-based nucleic acid drug delivery. The launch expands the company's pharmaceutical lipid portfolio to support mRNA vaccines, gene therapies, and other advanced therapeutics requiring efficient lipid delivery systems.

Report Scope

Segmentation

By Product 5
  • Triglycerides
  • Phospholipids
  • Sphingolipids
  • Cholesterol
  • Fatty Acids
By Source 3
  • Synthetic
  • Semi-synthetic
  • Natural
By Form 3
  • Liquid
  • Semi-solid
  • Solid
By Application 6
  • Conventional Lipid-based Drug Delivery Systems
  • Self-Emulsifying Drug Delivery Systems
  • Self-Micro Emulsifying Drug Delivery Systems
  • Liposomes
  • Solid Lipid Nanoparticles
  • Nanostructured Lipid Carriers
By Route of Administration 7
  • Oral
  • Tablet
  • Solution
  • Parenteral
  • Intravenous
  • Intramuscular (Vaccines)
  • Topical

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage ABITEC Corporation (ABF Ingredients) · BASF SE · Croda International Plc · CordenPharma · NOF (Nippon Oil & Fats) Corporation
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Reportto Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The pharmaceuticals lipids market size is valued at USD 5.73 Billion in 2026 and is projected to reach USD 8.60 Billion by 2034, at a CAGR of 5.2% during the forecast period 2026-2034.
North America dominated the market with a share of 39.5% in 2025.
The leading manufacturers in this market are ABITEC Corporation, BASF SE, Croda International Plc, CordenPharma, NOF Corporation.
The pharmaceuticals lipids market is projected to grow at a CAGR of 5.2% during the forecast period of 2026 2034.
About the Author
Ismail Sutaria
Ismail Sutaria
Research Head

Ismail Sutaria is Research Head at Straits Research with over 12 years of experience in market intelligence, industry research, and strategic advisory across chemicals, materials, packaging, industrial machinery, and energy markets. He specializes in market sizing and forecasting, competitive intelligence, value chain analysis, demand assessment, and commercial due diligence.

Over the course of his career, Ismail has led and contributed to numerous industry studies covering specialty chemicals, advanced materials, industrial technologies, manufacturing equipment, renewable energy, and sustainable packaging. His research focuses on evaluating market trends, technology adoption, competitive dynamics, regulatory developments, and growth opportunities to support informed business and investment decisions.

His expertise includes market forecasting, industry benchmarking, supply-demand analysis, pricing assessment, and strategic market evaluation across global and regional markets.

Report Details
−
Trusted by Industry Leaders
LG ElectronicsAMCAD EngineeringKOBE STEEL LTD.Hindustan National Glass & Industries LimitedVoith GroupInternational PaperHansol PaperWhirlpool CorporationSonySamsung ElectronicsQualcommGoogleFiservVeto-PharmaNippon Becton DickinsonMerckArgon Medical DevicesAbbottAjinomotoDenonDoosanMeiji Seika Kaisha LtdLG ChemicalsLCY chemical groupBayerAirraneBASFToyota IndustriesNissan MotorsNeenahMitsubishiHyundai Motor CompanyHondaCRP Industries IncpewagLGEPanasonicLubrizol CorporationLeonardoJohnson & JohnsonHB FullerMITSUBISHI CHEMICALHyundai MobisAmazon
Request SampleOrder Report Now